Randomized, Double Blind, Placebo Controlled, Parallel Groups Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF-680 "After Multiple Oral Doses" in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 14 May 2015
Price : $35 *
At a glance
- Drugs PBF 680 (Primary)
- Indications Asthma
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 02 Dec 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 07 Aug 2014 New trial record